GoodRx Holdings (GDRX) Net Shares Issued and Repurchased (2020 - 2022)

GoodRx Holdings has disclosed Net Shares Issued and Repurchased across 3 years of filings, most recently posting $7.6 million for Q4 2022.

• In Q4 2022, Net Shares Issued and Repurchased rose 2656.36% year-over-year to $7.6 million; the TTM figure through Dec 2022 stood at $7.6 million (up 2656.36% YoY), while the FY2022 annual figure was $7.6 million, up 2656.36% from the prior year.
• Net Shares Issued and Repurchased came in at $7.6 million for Q4 2022 at GoodRx Holdings, up from $2.6 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $10.0 million in Q4 2020 to a low of $275000.0 in Q4 2021.
• Average Net Shares Issued and Repurchased over 3 years is $3.6 million, with a median of $3.1 million recorded in 2020.
• Year-over-year, Net Shares Issued and Repurchased plunged 97.26% in 2021 and surged 2656.36% in 2022.
• Over 3 years, Net Shares Issued and Repurchased stood at $10.0 million in 2020, then sank by 97.26% to $275000.0 in 2021, then surged by 2656.36% to $7.6 million in 2022.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $7.6 million in Q4 2022, $2.6 million in Q3 2022, and $3.8 million in Q2 2022.